The lawsuit marks the latest salvo in the nationwide redistricting battle ahead of the 2026 midterm elections.

Recursion Pharmaceuticals has designated its top research executive, Najat Khan, to succeed co-founder Chris Gibson as president and chief executive of the clinical-stage biotechnology company, ...

Recursion CEO Chris Gibson is out after 12 years as the ambitious ‘techbio’ company positions itself for its next phase of AI ...

Reports Q3 revenue $5.2M, consensus $19.36M. Cash, cash equivalents and restricted cash were $667.1M as of September 30, compared to $603.0M as of ...

SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $162.3 million in its third quarter. The Salt Lake City-based company said it had a ...

Amidst the decline of reefs worldwide, UCR scientists have launched a $1.1 million project to uncover how coral regains life-giving algae after suffering from heat stress.

WASHINGTON, D.C. – Senate Republicans are still a few votes short of reaching the 60-vote threshold to pass their government funding bill. Some suggest the Senate should use a rare legislative ...

Abstract: Stealthy false data injection attack (FDIA) that intentionally modifies measurement data of smart grid meters to bypass the traditional bad data detection module is one of menacing cyber ...

What President Donald Trump’s latest memorandum targeting civil society does, does not, and cannot do. Nonprofits, their donors, and activists striving for a more equal, just, and fair country and ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...